News

Video

Managing the complexities of glaucoma care with Ying Han, MD, PhD

Ying Han, MD, PhD discusses glaucoma management strategies, including transitioning care between ophthalmologists and optometrists, improving diagnosis, and the hope for future glaucoma developments.

At the Glaucoma 360 meeting that was held in San Francisco, California, Ophthalmology Times has the opportunity to interview Ying Han, MD, PhD, a professor of ophthalmology and glaucoma specialist from the University of California San Francisco.

At the event, Han presented on glaucoma management strategies and outlined approaches for transitioning care between ophthalmologists and optometrists to best serve patients and monitor their glaucoma progression. The first approach of this management involved completely transferring the care of stable glaucoma patients to optometrists, with the optometrists referring patients back to the ophthalmologist if any active issues arose. The second approach was an alternating care model, where ophthalmologists and optometrists would share the management of patients who were not fully stabilized, with the ophthalmologist taking over if the patient's condition worsened to a point of surgical intervention or presented acute symptoms or vision loss.

Han also highlighted the need for improved glaucoma diagnosis, noting the significant number of "glaucoma suspect" patients whose precise diagnosis remained uncertain. She suggested that more precise diagnosis at the molecular level could lead to more effective treatment strategies. Additionally, Han expressed a desire for the future developments of a glaucoma surgery with a success rate comparable to the highly successful phacoemulsification procedure used for cataract surgery. She feels this would be an important step forward in providing care to patients with glaucoma.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.